Human Metabolome Technologies Inc
TSE:6090
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
604
869
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Relative Value
The Relative Value of one
Human Metabolome Technologies Inc
stock under the Base Case scenario is
626.87
JPY.
Compared to the current market price of 698 JPY,
Human Metabolome Technologies Inc
is
Overvalued by 10%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Human Metabolome Technologies Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Human Metabolome Technologies Inc
TSE:6090
|
4B JPY | 2.9 | 20.3 | 10.4 | 16.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.3T USD | 460.4 | 5 453.9 | 1 599.2 | 3 212.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
236.4B USD | 5.4 | 36 | 25.4 | 32.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
166B USD | 6.8 | 47.4 | 25.4 | 38.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.6B CHF | 5.4 | 51.9 | 39.1 | 39.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
40.1B USD | 2.5 | 31.2 | 15 | 22.5 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
276.2B CNY | 6.3 | 18.5 | 18.6 | 18.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
38.3B USD | 5.5 | 29.4 | 22.8 | 27.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
83.2T KRW | 15.2 | 52.3 | 30.8 | 41 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.7B USD | 7.3 | 34.4 | 24.8 | 27.5 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
20.3B EUR | 6.9 | 76.6 | 27.1 | 44.5 |
